[1] |
中华医学会糖尿病学分会.中国2 型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
|
[2] |
Yang P,Feng J,Peng Q,et al.Advanced Glycation End Products:Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes[J].Oxid Med Cell Longev,2019:9570616.
|
[3] |
Vigersky RA,Mcmahon C.The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes[J].Diabetes Technol Ther,2019,21(2):81-85.
|
[4] |
Bomholt T,Adrian T,Nrgaard K,et al.The Use of HbA1c,Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including Dialysis[J].Nephron,2021,145(1):14-19.
|
[5] |
Wang Z,Xing G,Zhang L.Glycated albumin level is significantly decreased in patients suffering nephrotic syndrome[J].Prog Mol Biol Transl Sci,2019,162:307-319.
|
[6] |
Zendjabil M.Glycated albumin[J].Clin Chim Acta,2020,502:240-244.
|
[7] |
Vijayaraghavan B,Padmanabhan G,Ramanathan K.Determination of serum glycated albumin and high sensitivity Creactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients[J].Afr Health Sci,2020,20(1):308-313.
|
[8] |
Eckart A,Struja T,Kutz A,et al.Relationship of Nutritional Status,Inflammation,and Serum Albumin Levels During Acute Illness:A Prospective Study[J].Am J Med,2020,133(6):713-722.
|
[9] |
Sproston NR,Ashworth JJ.Role of C-Reactive Protein at Sites of Inflammation and Infection[J].Front Immunol,2018,9:754.
|
[10] |
Wang HJ,Lo WY,Lin LJ.Angiotensin-(1-7)decreases glycated albumin-induced endothelial interleukin-6 expression via modulation of miR-146a[J].Biochem Biophys Res Commun,2013,430(3):1157-1163.
|
[11] |
Roohk HV,Zaidi AR,Patel D.Glycated albumin (GA)and inflammation:role of GA as a potential marker of inflammation[J].Inflamm Res,2018,67(1):21-30.
|
[19] |
Soysal P,Arik F,Smtth L,et al.Inflammation,Frailty and Cardiovascular Disease[J].Adv Exp Med Biol,2020,1216:55-64.
|
[22] |
Kolluru GK,Bir SC,Kevil CG.Endothelial dysfunction and diabetes:effects on angiogenesis,vascular remodeling,and wound healing[J].Int J Vasc Med,2012:918267.
|
[23] |
Vidhya G,Anusha B.Diaretinopathy database-A gene database for diabetic retinopathy[J].Bioinformation,2014,10(4):235-240
|
[12] |
Poznyak A,Grechko AV,Poggio P,et al.The Diabetes Mellitus-Atherosclerosis Connection:The Role of Lipid and Glucose Metabolism and Chronic Inflammation[J].Int J Mol Sci,2020,21(5):1835.
|
[13] |
Bakkar NZ,Dwaib HS,Fares S,et al.Cardiac Autonomic Neuropathy:A Progressive Consequence of Chronic Low-Grade Inflammation in Type 2 Diabetes and Related Metabolic Disorders[J].Int J Mol Sci,2020,21(23):9005.
|
[14] |
Zhang ZQ,Yang YF,Yan JR,et al.Advanced glycated albumin induces macrophage pyroptosis via upregulating nucleotide-binding oligomerization domain-like receptor protein 3[J].Sheng Li Xue Bao,2019,71(6):846-854.
|
[15] |
Martinez Fernandez A,Regazzoni I,Brioschi M,et al.Prooxidant and pro-inflammatory effects of glycated albumin on cardiomyocytes[J].Free Radic Biol Med,2019,144:245-255.
|
[16] |
Ieronymaki E,Daskalaki M G,Lyroni K,et al.Insulin Signaling and Insulin Resistance Facilitate Trained Immunity in Macrophages Through Metabolic and Epigenetic Changes[J].Front Immunol,2019,10:1330.
|
[17] |
Kojta I,Chacinska M,Blachnio-zabielska A.Obesity,Bioactive Lipids,and Adipose Tissue Inflammation in Insulin Resistance[J].Nutrients,2020,12(5):1305.
|
[18] |
Amin MN,Hussain MS,Sarwar MS,et al.How the association between obesity and inflammation may lead to insulin resistance and cancer[J].Diabetes Metab Syndr,2019,13(2):1213-1224.
|
[20] |
Roohk HV,Zaidi AR,Patel D.Glycated albumin (GA)and inflammation:role of GA as a potential marker of inflammation[J].Inflamm Res,2018,67(1):21-30.
|
[21] |
Paradela-Dobarro B,Bravo SB,Rozados-Luis A,et al.Inflammatory effects ofin vivoglycated albumin from cardiovascular patients[J].Biomed Pharmacother,2019,113:108763.
|
[24] |
Schalkwijk C,Lieuw-a-Fa M,van Hinsbergh V,et al.Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy[J].Semin Vasc Med,2002,2(2):191-197.
|
[25] |
Chen S,Cohen MP,Ziyadeh FN.Amadori-glycated albumin in diabetic nephropathy:pathophysiologic connections[J].Kidney Int Suppl,2000,77:S40-44.
|
[26] |
Pan J,Li Q,Zhang L,et al.Serum glycated albumin predicts the progression of diabetic retinopathy-a five year retrospective longitudinal study[J].J Diabetes Complications,2014,28(6):772-778.
|
[27] |
Abcouwer S.Angiogenic Factors and Cytokines in Diabetic Retinopathy[J].J Clin Cell Immunol,2013,Suppl 1(11):1-12.
|
[28] |
Dong N,Xu B,Shi H,Lu Y,et al.miR-124 Regulates Amadori-Glycated Albumin-Induced Retinal Microglial Activation and Inflammation by Targeting Rac1[J].Invest Ophthalmol Vis Sci,2016,57(6):2522-2532.
|
[29] |
Vos FE,Schollum JB,Walker RJ.Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease[J].NDT Plus,2011,4(6):368-375.
|
[30] |
Jun JE,Hur KY,Lee YB,et al.Glycated albumin predicts the development of early diabetic nephropathy in patients with type 2 diabetes[J].Diabetes Metab,2018,44(2):178-180.
|
[31] |
Lu L,Pu L,Xu X,et al.Association of serum levels of glycated albumin,C-reactive protein and tumor necrosis factor-a with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus[J].Clin Biochem,2007,40(11):810-816.
|
[32] |
Umayahara Y,Fujita Y,Watnabe H,et al.Association of glycated albumin to HbA1c ratio with diabetic retinopathy but not diabetic nephropathy in patients with type 2 diabetes[J].Clin Biochem,2017,50(6):270-273.
|